Riggs Arthur 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Riggs Arthur
10% Owner
Transactions
- Purchase
Common Stock
2018-12-07$0.50/sh+1,260,000$630,000→ 6,110,000 total(indirect: By Trust) - Purchase
Warrants to Purchase Common Stock
2018-12-07$0.50/sh+1,260,000$630,000→ 1,260,000 total(indirect: By Trust)Exercise: $1.00From: 2018-12-07Exp: 2022-11-30→ Common Stock (1,260,000 underlying)
Footnotes (1)
- [F1]The reporting person acquired 1,260,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50 per Unit.